Mortality related to COVID-19 in patients with rheumatic and musculoskeletal diseases, first wave of the outbreak: a single-center study.
Dalifer Freites NuñezLeticia LeonAlfredo Madrid GarciaJose Ignacio Colomer ArceArkaitz MucientesBenjamín Fernández GutiérrezLuis Rodriguez-RodriguezInés Pérez San CristóbalPaula ÁlvarezCristina Martinez PradaLydia AbasoloPublished in: Therapeutic advances in musculoskeletal disease (2022)
- The presence of comorbidities in RMDs patients represents a greater risk than the different types of RMDs themselves, in the development of COVID-19 fatal outcome. It is important to integrate the control of comorbidities in the daily management.